Drug
Intervention Group 3
Intervention Group 3 is a pharmaceutical drug with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
1
33%
Ph not_applicable
2
67%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(1)
Other(1)
Detailed Status
Completed1
unknown1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (33.3%)
N/A2 (66.7%)
Trials by Status
completed133%
unknown133%
recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
recruitingphase_2
A Phase II Clinical Trial of the Safety and Efficacy of SAL056 at Different Doses and Dosing Regimens
NCT07579936
unknownnot_applicable
The Effects of Different Physiotherapy Approaches in Stable COPD Patients.
NCT05335304
completednot_applicable
Aromatherapy for Anxiety and Self-esteem: Clinical Trial
NCT01963689
Clinical Trials (3)
Showing 3 of 3 trials
NCT07579936Phase 2
A Phase II Clinical Trial of the Safety and Efficacy of SAL056 at Different Doses and Dosing Regimens
NCT05335304Not Applicable
The Effects of Different Physiotherapy Approaches in Stable COPD Patients.
NCT01963689Not Applicable
Aromatherapy for Anxiety and Self-esteem: Clinical Trial
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3